MLchartDataset catalogue

zelavespib

Term · Oncology and biomedicine · MLC-T-ONC-017657

A purine-based heat shock protein 90 (Hsp90) inhibitor with potential antineoplastic activity. Zelavespib specifically inhibits active Hsp90, thereby inhibiting its chaperone function and promoting the proteasomal degradation of oncogenic signaling proteins involved in tumor cell proliferation and survival. This may result in the inhibition of cellular proliferation in susceptible tumor cell populations. Hsp90, a molecular chaperone protein, is upregulated in a variety of tumor cell types.

Table 1. Record
IdentifierMLC-T-ONC-017657
FieldOncology and biomedicine
SynonymsHsp90 inhibitor PU-H71
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017657",
  "term": "zelavespib",
  "field": "Oncology and biomedicine",
  "definition": "A purine-based heat shock protein 90 (Hsp90) inhibitor with potential antineoplastic activity. Zelavespib specifically inhibits active Hsp90, thereby inhibiting its chaperone function and promoting the proteasomal degradation of oncogenic signaling proteins involved in tumor cell proliferation and survival. This may result in the inhibition of cellular proliferation in susceptible tumor cell populations. Hsp90, a molecular chaperone protein, is upregulated in a variety of tumor cell types.",
  "synonyms": [
    "Hsp90 inhibitor PU-H71"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/zelavespib/"
}

Record 17,616 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.